Publications by authors named "M Mark"

Claim this Profile
F
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastases.
Lorenz Frehner, Sämi Schär, Stefanie Hayoz, Verena Petermichl, Philip Speicher, Michael Mark

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Concurrent Neurophysiological Responses to Dynamic In-Motion Physical and Cognitive Functional Tasks in Division I Athletes.
Thomas Palmer, Bob Mangine, Audrey Hill-Lindsay, Joseph Clark, Bradley Jacobs, Michael Mark

Sports Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.
L Frehner, S Schär, S Hayoz, M Guckenberger, T Finazzi, M Mark

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purkinje cell activity changes in cerebellar subregions during fear conditioning.
Johanna Pakusch, Tejas Nair, Thomas Grosch, Melanie D Mark

Front Behav Neurosci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19).
Alfredo Addeo, Daniel Dietrich, Nicolas Mach, Michael Thomas Mark, Markus Joerger

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis